The information below details the components of this test. For overall setup schedule, see Performing lab & setup schedule.
Test code | Test name | Orderable separately | Setup schedule |
|---|---|---|---|
| 216 | ANTITHROMBIN III ACTIVITY | Yes | Not provided |
| 36552 | B2 GLYCOPROTEIN I (IGA)AB | Yes | Not provided |
| 36554 | B2 GLYCOPROTEIN I (IGG)AB | Yes | Not provided |
| 36553 | B2 GLYCOPROTEIN I (IGM)AB | Yes | Not provided |
| 4661 | CARDIOLIPIN AB (IGA) | Yes | Not provided |
| 4662 | CARDIOLIPIN AB (IGG) | Yes | Not provided |
| 4663 | CARDIOLIPIN AB (IGM) | Yes | Not provided |
| 19682 | Coagulation Consultation | Yes | Not provided |
| %17900 | FACTOR V (LEIDEN)MUTATION ANALYSIS | No | Not provided |
| 31789 | HOMOCYSTEINE | Yes | Not provided |
| 7079 | LUPUS ANTICOAGULANTEVALUATION WITH REFLEX | Yes | Not provided |
| 11443 | PHOSPHATIDYLSERINE/PROTHROMBIN AB (IGG) | Yes | Not provided |
| 11446 | PHOSPHATIDYLSERINE/PROTHROMBIN AB (IGM) | Yes | Not provided |
| 1777 | PROTEIN C, ACTIVITY | Yes | Not provided |
| 10170 | PROTEIN S ANTIGEN, FREE | Yes | Not provided |
| %17909 | PROTHROMBIN (FACTOR II)20210G>A MUTATION | No | Not provided |
Lupus Anticoagulant Evaluation with Reflex (PTT-LA and dRVVT with Reflex Confirmations)
Protein C Activity
Protein S Antigen, Free
Antithrombin III Activity
Cardiolipin Antibodies (IgA, IgG, IgM)
Beta-2-Glycoprotein I Antibodies (IgG, IgA, IgM)
Phosphatidylserine/Prothrombin (PS/PT) Antibodies (IgG, IgM)
Homocysteine
Prothrombin (Factor II) 20210G→A Mutation Analysis
Factor V (Leiden) Mutation Analysis
Coagulation Consultation
If PTT-LA Screen is prolonged (>40 seconds), then Hexagonal Phase Confirmation will be performed at an additional charge (CPT code(s): 85598).
If Hexagonal Phase Confirmation is positive or weakly positive, then Thrombin Clotting Time will be performed at an additional charge (CPT code(s): 85670.
If dRVVT Screen is prolonged (>45 seconds), then dRVVT Confirm will be performed at an additional charge (CPT code(s): 85597).
If dRVVT Confirm is positive, then dRVVT 1:1 Mixing Study will be performed at an additional charge (CPT code(s): 85613).
Chromogenic • Clotting Assay • Enzyme Immunoassay (EIA) • Immunoassay (IA) • Immunoturbidimetric • Polymerase Chain Reaction & Detection
Prothrombin (Factor II) 20210G→A Mutation Analysis and Factor V (Leiden) Mutation Analysis: This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Specimen requirements | |
|---|---|
| Patient preparation | None Specified |
| Preferred specimen(s) | 5 mL whole blood collected in an EDTA (lavender-top) tube and 1 mL frozen platelet-poor plasma collected in each of four 3.2% sodium citrate (light blue-top) tubes and 3 mL frozen serum collected in a red-top tube (no gel) |
| Minimum volume | 3 mL whole blood • 0.5 mL plasma, each specimen • 0.5 mL serum |
| Collection instructions | Whole blood sample is for the Factor V Mutation Analysis and Prothrombin (Factor II) Mutation Analysis. Serum sample is for the Homocysteine. Red-top tubes: Place the specimen in a refrigerator or ice bath for 30 minutes after collection. Centrifuge the specimen as soon as possible after complete clot formation has taken place. Transfer the serum to a plastic screw-capped vial. Barrier gel separator tubes: Place the specimen in a refrigerator for 30 minutes after collection. Centrifuge the specimen as soon as possible after complete clot formation has taken place. Do not place barrier tubes in an ice bath as freezing may prevent the barrier gel from adequately separating serum from cells. Platelet-poor plasma is for remaining tests. Platelet-poor plasma: Centrifuge light blue-top tube 15 minutes at approximately 1500 x g within 60 minutes of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into four plastic vials. Plasma must be free of platelets (<10,000/mcL). Freeze immediately and ship on dry ice. Serum and plasma must remain frozen during storage and shipment. All requests for coagulation assays should include a brief patient history and other pertinent clinical information. |
| Transport container | Transport tube(s) |
| Transport temperature | Whole blood: Room temperature Plasma and serum: Frozen |
| Specimen stability | Whole blood Room temperature: 8 days Refrigerated: 8 days Frozen: 30 days Plasma Room temperature: Unacceptable Refrigerated: Unacceptable Frozen: 14 days Serum Room temperature: 4 days Refrigerated: 14 days Frozen: 6 months |
| Reject criteria | Gross hemolysis • Grossly lipemic |
The Result and LOINC® information listed below should not be used for electronic interface maintenance with Quest Diagnostics. Please contact the Quest Diagnostics Connectivity Help Desk for more information at 800-697-9302.
NOTE: The codes listed in the table are not orderable Test Codes
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 30021100 | PROTEIN C, ACTIVITY | 27819-2 | Protein C actual/Normal |
| 30035205 | PTT-LA SCREEN | 34571-0 | Coagulation |
| 30035405 | DRVVT SCREEN | 6303-2 | Coagulation |
| 30035900 | LUPUS ANTICOAGULANT | 75514-0 | Lupus anticoagulant two screening tests W Reflex |
| 31000100 | ANTITHROMBIN III ACTIVITY | 27811-9 | Antithrombin actual/Normal |
| 45000400 | CARDIOLIPIN AB (IGG) | 3181-5 | Cardiolipin Ab.IgG |
| 45000500 | CARDIOLIPIN AB (IGM) | 3182-3 | Cardiolipin Ab.IgM |
| 45000600 | CARDIOLIPIN AB (IGA) | 5076-5 | Cardiolipin Ab.IgA |
| 45030401 | B2 GLYCOPROTEIN I (IGG)AB | 16135-6 | Beta 2 glycoprotein 1 Ab.IgG |
| 45030402 | B2 GLYCOPROTEIN I (IGM)AB | 16136-4 | Beta 2 glycoprotein 1 Ab.IgM |
| 45030403 | B2 GLYCOPROTEIN I (IGA)AB | 21108-6 | Beta 2 glycoprotein 1 Ab.IgA |
| 45995187 | PROTEIN S ANTIGEN, FREE | 27821-8 | Protein S.free Ag actual/Normal |
| 50131900 | HOMOCYSTEINE | 13965-9 | Homocysteine |
| 85985660 | FACTOR V (LEIDEN) MUTATION | 21668-9 | F5 gene.p.Arg506Gln |
| 85994504 | PROTHROMBIN (FACTOR II) 20210G>A MUTATION | 24475-6 | F2 gene.c.20210G>A |
| 86003436 | CONSULTATION LEVEL | No LOINC exists | |
| 86003437 | INTERPRETATION | 56850-1 | Interpretation and review of laboratory results |
| 86006650 | INTERPRETATION | 24476-4 | F2 gene mutations |
| 86011544 | INTERPRETATION | 21667-1 | F5 gene mutations |
| 86031398 | PHOSPHATIDYLSERINE/ PROTHROMBIN AB (IGG) | 85359-8 | Phosphatidylserine-prothrombin complex Ab.IgG |
| 86031399 | PHOSPHATIDYLSERINE/ PROTHROMBIN AB (IGM) | 85358-0 | Phosphatidylserine-prothrombin complex Ab.IgM |
| Quest Diagnostics Nichols Institute-Chantilly VA |
| 14225 Newbrook Drive |
| Chantilly, VA 20151-2228 |
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
*The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.